Laporan Laba Rugi ELTP - TTM - Elite Pharmaceuticals, Inc.

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Elite Pharmaceuticals, Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2021 12-31	2022 03-31	2022 06-30	2022 09-30	2022 12-31	2023 03-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31	2025 03-31	2025 06-30
Revenue	25	26	25	25	26	29	32	33	33	33	34	35	41	47	57	66	71	70	84	105
Change (%)		3.98	-2.12	-1.90	4.65	11.24	11.30	1.91	0.08	0.85	2.92	3.83	15.71	15.31	19.67	17.35	7.11	-1.65	20.07	25.47
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	13	13	14	12	13	16	17	18	18	17	18	18	21	26	30	36	39	39	44	47
Change (%)		3.69	0.32	-7.84	7.80	17.23	10.98	0.98	0.06	-5.84	5.67	3.16	16.28	21.71	18.06	20.15	8.17	-0.64	12.46	6.04
% of Revenue	52.09	51.95	53.24	50.02	51.53	54.30	54.14	53.65	53.64	50.08	51.42	51.08	51.33	54.18	53.45	54.73	55.27	55.84	52.30	44.20

Gross Operating Profit	12	12	12	12	13	13	15	15	15	17	17	17	20	22	26	30	32	31	40	59
Change (%)		4.28	-4.76	4.86	1.50	4.87	11.69	3.00	0.11	8.60	0.16	4.54	15.12	8.57	21.57	14.13	5.82	-2.90	29.69	46.78
% of Revenue	47.91	48.05	46.76	49.98	48.47	45.70	45.86	46.35	46.36	49.92	48.58	48.92	48.67	45.82	46.55	45.27	44.73	44.16	47.70	55.80

SG&A	4	4	3	4	4	4	4	5	5	6	5	5	5	6	7	8	8	9	9	11
Change (%)		-1.76	-4.70	5.97	3.78	2.92	18.60	14.51	5.15	9.76	-12.79	-0.91	7.42	5.46	26.07	4.72	9.81	12.31	-2.17	15.55
% of Revenue	14.29	13.50	13.14	14.20	14.08	13.03	13.88	15.60	16.39	17.84	15.11	14.42	13.39	12.25	12.90	11.51	11.80	13.48	10.98	10.11

R&D	6	6	5	5	5	5	4	4	4	5	6	6	8	8	7	8	7	8	8	7
Change (%)		4.64	-12.42	5.05	0.12	-5.38	-20.37	-6.09	1.92	16.40	37.36	3.03	21.78	-2.42	-9.32	14.82	-8.25	5.38	4.24	-6.13
% of Revenue	22.37	22.51	20.14	21.57	20.64	17.55	12.56	11.57	11.78	13.60	18.15	18.01	18.96	16.04	12.16	11.89	10.19	10.92	9.48	7.09

OpEx	23	24	23	23	24	26	27	28	28	28	30	31	36	40	46	53	57	58	63	66
Change (%)		2.91	-3.55	-2.65	4.75	8.84	5.25	2.05	1.33	0.54	6.77	2.41	15.29	13.22	13.59	16.50	5.92	2.23	8.68	5.68
% of Revenue	94.03	93.07	91.71	91.01	91.09	89.13	84.28	84.40	85.45	85.19	88.38	87.17	86.86	85.28	80.95	80.36	79.47	82.61	74.77	62.98

Operating Income	1	2	2	2	2	3	5	5	5	5	4	5	5	7	11	13	15	12	21	39
Change (%)		20.84	17.07	6.39	3.68	35.76	60.90	1.13	-6.66	2.67	-19.24	14.60	18.57	29.18	54.88	20.97	11.95	-16.67	74.15	84.11
% of Revenue	5.97	6.93	8.29	8.99	8.91	10.87	15.72	15.60	14.55	14.81	11.62	12.83	13.14	14.72	19.05	19.64	20.53	17.39	25.23	37.02

Interest Expense	-0	-0	-0	-0	-0	-0	-0	-0	-1	-1	-1	-1	-1	-1	-1	-1	-1	-1	-1	-1
Change (%)		-4.55	-16.55	-12.92	-16.22	-22.32	30.38	89.09	55.05	50.73	31.27	-8.75	-11.06	-22.26	-16.15	22.32	17.32	-5.21	-3.53	-11.89
% of Revenue	-1.31	-1.20	-1.02	-0.91	-0.73	-0.51	-0.59	-1.10	-1.71	-2.55	-3.26	-2.86	-2.20	-1.48	-1.04	-1.08	-1.19	-1.14	-0.92	-0.65

Net Income	3	7	5	6	6	6	9	7	7	7	4	4	18	16	20	20	-6	-18	-4	-11
Change (%)		147.00	-21.81	25.78	-10.70	4.75	48.63	-23.41	-4.14	10.51	-50.67	23.47	305.14	-12.71	29.29	-2.62	-132.62	181.56	-76.01	150.66
% of Revenue	10.56	25.10	20.05	25.70	21.93	20.65	27.58	20.73	19.85	21.76	10.43	12.40	43.42	32.87	35.51	29.47	-8.98	-25.70	-5.13	-10.26

Source: Capital IQ

Elite Pharmaceuticals, Inc. - Laporan Laba Rugi (TTM)

Laporan Laba Rugi (TTM)